30 related articles for article (PubMed ID: 32096165)
1. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
[TBL] [Abstract][Full Text] [Related]
2. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
[TBL] [Abstract][Full Text] [Related]
3. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
[TBL] [Abstract][Full Text] [Related]
4. EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability.
Wang H; Wang L; Zhang S; Liu Q; Gao F
Cancer Cell Int; 2024 May; 24(1):175. PubMed ID: 38764053
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "Knockdown EZH2 attenuates cerebral ischemia-reperfusion injury via regulating microRNA-30d-3p methylation and USP22" [Brain Res. Bull. 169 (2021) 25-34].
Jin D; Wei W; Song C; Han P; Leng X
Brain Res Bull; 2022 Oct; 188():38. PubMed ID: 35907322
[No Abstract] [Full Text] [Related]
6. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
7. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
9. LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a.
Zheng TZ; Li YT; Li WJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1913-1921. PubMed ID: 32141560
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of gastric cancer: current advancement.
Jiang T; Mei L; Yang X; Sun T; Wang Z; Ji Y
Heliyon; 2022 Oct; 8(10):e10899. PubMed ID: 36247151
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1
Bai B; Liu Y; Fu XM; Qin HY; Li GK; Wang HC; Sun SL
Oxid Med Cell Longev; 2022; 2022():7608712. PubMed ID: 36071871
[TBL] [Abstract][Full Text] [Related]
12. Crucial Roles of miR-625 in Human Cancer.
Zhang M; Xiong F; Zhang S; Guo W; He Y
Front Med (Lausanne); 2022; 9():845094. PubMed ID: 35308517
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk.
Altieri R; Barbagallo D; Certo F; Broggi G; Ragusa M; Di Pietro C; Caltabiano R; Magro G; Peschillo S; Purrello M; Barbagallo G
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33561993
[TBL] [Abstract][Full Text] [Related]
15. miR-4636 inhibits tumor cell proliferation, migration and invasion, and serves as a candidate clinical biomarker for gastric cancer.
Tang J; Hu Y; Zhang C; Gong C
Oncol Lett; 2021 Jan; 21(1):33. PubMed ID: 33262825
[TBL] [Abstract][Full Text] [Related]
16. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.
Son SW; Lee HY; Moeng S; Kuh HJ; Choi SY; Park JK
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066509
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
18. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
19. LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.
Chen GR; Sun W; Zheng K; Zhu W
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3648-3656. PubMed ID: 32329840
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
